PerkinElmer (NYSE:PKI) is under federal scrutiny for alleged involvement in a scam to bill Medicare for tens of thousands of unnecessary genetic cancer tests, according to a report by Reuters. The news agency cited three unidentified sources and government documents linking the Waltham, Mass.-based diagnostic and scientific instrument company to the probe. PerkinElmer acknowledged that it has […]
CMS recommends postponing most elective procedures
The Centers for Medicare and Medicaid Services (CMS) released guidance late yesterday asking healthcare providers to postpone adult elective surgeries and procedures, including dental procedures, until further notice. The move is an attempt to preserve the supply of ventilators and personal protective equipment such as masks and gowns while protecting patients and staff from exposure […]
Competitor’s lawsuit against Tactile Medical can proceed
A U.S. District Court judge in southern Texas has denied a motion from Tactile Medical (NSDQ: TCMD) to dismiss a competitor’s qui tam complaint. Veterans First Medical Supply (Houston) claimed in its lawsuit filed in early 2019 that Tactile is defrauding Medicare and Medicaid because it contracts with hundreds of clinicians to provide at-home setup […]
CMS considers extending Medicare coverage for heart devices
The Centers for Medicare and Medicaid Services (CMS) may extend coverage for artificial hearts and ventricular assist devices (VADs). Currently, Medicare covers artificial hearts for beneficiaries enrolled in a CMS-approved clinical study, a status that hasn’t been updated since 2008. Artificial heart-maker SynCardia wrote a letter last year to CMS asking it to extend coverage […]
House bill asks CMS to cover breakthrough devices for Medicare patients
U.S. Rep. Suzan DelBene (D-Wash) reintroduced a bill today to improve Medicare patient access to breakthrough medical devices. The Ensuring Patient Access to Critical Breakthrough Products Act of 2019 (H.R. 5333) would require Medicare to temporarily cover all devices approved through the FDA’s breakthrough pathway for three years, during which the Centers for Medicare and […]
NanoVibronix wins reimbursement from CMS for PainShield device
NanoVibronix (NSDQ:NAOV) announced today that it won a unique reimbursement code from the Centers for Medicare and Medicaid for its PainShield surface acoustic wave portable ultrasonic therapeutic device. The Elmsford, N.Y.–based company develops medical devices based around its low-intensity SAW technology that allows the creation of low-frequency ultrasound waves that can be used in multiple medical […]
South Dakota provider to pay $20m to settle POD case
The U.S. Justice Dept. said yesterday that Sanford Health, Sanford Medical Center and Sanford Clinic of Sioux Falls, S.D., agreed to pay more than $20 million to resolve allegations that they submitted false claims to federal healthcare programs. The allegations include violations of the Anti-Kickback Statute and medically unnecessary spinal surgeries, according to a statement […]
Jury convicts doc of re-using single-use catheters
Last week a federal jury reportedly found a southern California doctor guilty after the reuse of single-use catheters and unnecessary medical procedures for Medicare beneficiaries were allegedly carried out under his supervision. Dr. Donald Woo Lee of Temecula, Calif. was found guilty of adulterating a medical device along with seven counts of healthcare fraud, according […]
More reimbursement wins for Inspire Medical Systems
Inspire Medical Systems (NYSE:INSP) said yesterday that it received two additional draft Local Coverage Determinations for its minimally invasive therapy for sleep apnea. The latest proposals were issued by National Government Services and CGS Administrators, which represent a combined 12 states. The companies have different public comment periods, with NGS’s running from Sept. 26 to Nov. […]
LivaNova wins Medicare nod for nerve stimulation trial
Medicare has approved a LivaNova (NSDQ:LIVN) study of vagus nerve stimulation (VNS) to treat depression, the company said today. The Centers for Medicare and Medicaid Services accepted the London-based company’s protocol for a clinical trial to study the safety and effectiveness of adding VNS to traditional depression treatment in patients with treatment-resistant depression. Approval of […]
Inspire Medical adds more LCDs
Inspire Medical Systems (NYSE:INSP) yesterday said, for the second time this week, that two local coverage determination drafts were published for coverage of its sleep apnea therapy. Inspire Medical had two LCDs published August 26 by Medicare contractors Noridian Medicare and Palmetto GBA. Yesterday the Minneapolis-based company said Novitas Solutions and First Coast Service Options also […]
- 1
- 2
- 3
- …
- 30
- Next Page »
